Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

How did we get here? Until now, vaccines for all children under age 12 had been available under emergency use authorization ...

FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...

Since 2020, investors have been rallying behind shares of Pfizer and Germany's BioNTech, two companies that were poised to play a crucial role in helping bring an end to a devastating pandemic.

The amended dosing regimen was approved based on results from a post hoc analysis of the phase 2 MagnetisMM-3 trial.

The atopic dermatitis market, valued at USD 9.33 billion in 2024, is projected to grow at a CAGR of 15.10%, reaching USD 38.07 billion by 2034. Key d ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

The FDA Advisory Committee approved Pfizer for emergency use authorization for its Covid-19 vaccine on Thursday evening, ... The few votes against the approval did not question the vaccine’s ...

The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.

FDA approves Pfizer’s eczema treatment New York City-based Pfizer earned approval from the Food and Drug Administration for its topical drug Eucrisa, reports Reuters.

Arvinas and Pfizer have filed for U.S. Food and Drug Administration approval of their proposed breast-cancer drug vepdegestrant in certain patients with estrogen-receptor mutations. Arvinas on ...

The FDA granted full-approval to Pfizer’s meningococcal disease immunization, Penbraya, on Oct. 20. The new vaccine provides what Pfizer noted in a press release is the “broadest” protection ...